Corona virus disease also known as Covid -19 pandemic has represented major impact to health system and societies world-wide. There is no particular high risk seen among mother and fetus. In addition to these aspects specifically to Covid -19 and gestation that should be known by specialist in order to correctly diagnose disease, classify severity, distinguish obstetric complications with specific signs of Covid -19 and for taking most appropriate management decision.
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has exposed vulnerable populations to global health crisis. Mother and fetuses are particularly susceptible to poor outcome. There are very limited data how SARS-CoV-2 behaves in pregnant women & their infants. We pearly reviewed 52 gravida infected with covid-19 pneumonia. Out of which 25 symptomatic patients admitted to our hospital while 27 asymptomatic but Covid positive patients care taken on OPD basis followed by home quarantine for 14 days.
Aims & Objectives: 1) To summarize the clinical features of Covid-19 in pregnancy; 2) Any intervention helps for better maternal and perinatal outcome. 3) Safety profile of Remdesivir in third trimester of pregnancy with Covid-19 pneumonia.
Materials and Methods: This was a single-centre; meta-analysis performed at Sunshine global hospital
Vadodara Gujarat designated hospitals for pregnancy with COVID-19 in the epicentre of the SARS-CoV-2 outbreak and medical consultation/collaboration with Scientific Research Institute, Surendranagar, Gujarat.
We included pregnant women with COVID-19 from inpatient & outpatient department.
Pregnant women, Fetus, RTPCR, D-Dimer, CRP, Remdesivir, Covid -19.